| Breakdown | Feb 2026 | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 542.12B | 537.68B | 575.66B | 555.96B | 479.08B |
| Gross Profit | 191.24B | 191.48B | 209.10B | 192.01B | 168.65B |
| EBITDA | 66.43B | 103.07B | 92.35B | 93.20B | 74.07B |
| Net Income | 35.24B | 56.99B | 50.69B | 51.78B | 38.35B |
Balance Sheet | |||||
| Total Assets | 812.37B | 743.77B | 702.34B | 653.13B | 559.04B |
| Cash, Cash Equivalents and Short-Term Investments | 61.22B | 59.03B | 40.28B | 42.27B | 55.15B |
| Total Debt | 124.85B | 109.53B | 95.90B | 99.56B | 68.04B |
| Total Liabilities | 318.75B | 304.16B | 294.31B | 298.05B | 260.93B |
| Stockholders Equity | 483.54B | 431.19B | 399.34B | 347.50B | 291.23B |
Cash Flow | |||||
| Free Cash Flow | 5.93B | 19.20B | 23.59B | -24.14B | 25.01B |
| Operating Cash Flow | 52.17B | 56.51B | 54.62B | -2.21B | 49.23B |
| Investing Cash Flow | -44.22B | -21.29B | -29.35B | -19.69B | -24.16B |
| Financing Cash Flow | -8.63B | -15.67B | -29.42B | 7.20B | -22.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥192.38B | 16.57 | ― | 1.53% | 3.37% | 21.35% | |
72 Outperform | ¥138.53B | 3.86 | 8.07% | 2.64% | 79.29% | 35.48% | |
71 Outperform | ¥12.21T | 21.58 | 9.29% | 1.19% | 4.62% | 40.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥1.63T | 19.95 | 12.05% | 1.50% | 5.44% | -5.19% | |
59 Neutral | ¥51.66B | -60.12 | ― | 5.01% | -32.74% | -117.06% | |
58 Neutral | ¥1.28T | 40.59 | 8.39% | 1.49% | -2.18% | 30.16% |